Tonix Pharmaceuticals Holding Corp (TNXP)
0.2042
+0.01
(+7.47%)
USD |
NASDAQ |
Nov 21, 16:00
0.20
0.00 (0.00%)
After-Hours: 20:00
Tonix Pharmaceuticals Market Cap: 38.16M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 38.16M |
| November 20, 2024 | 35.51M |
| November 19, 2024 | 30.41M |
| November 18, 2024 | 24.86M |
| November 15, 2024 | 24.50M |
| November 14, 2024 | 26.17M |
| November 13, 2024 | 26.39M |
| November 12, 2024 | 27.10M |
| November 11, 2024 | 21.84M |
| November 08, 2024 | 21.94M |
| November 07, 2024 | 21.98M |
| November 06, 2024 | 21.79M |
| November 05, 2024 | 22.08M |
| November 04, 2024 | 22.07M |
| November 01, 2024 | 21.68M |
| October 31, 2024 | 22.61M |
| October 30, 2024 | 24.03M |
| October 29, 2024 | 26.15M |
| October 28, 2024 | 27.86M |
| October 25, 2024 | 25.76M |
| October 24, 2024 | 24.98M |
| October 23, 2024 | 26.15M |
| October 22, 2024 | 28.01M |
| October 21, 2024 | 29.55M |
| October 18, 2024 | 28.01M |
| Date | Value |
|---|---|
| October 17, 2024 | 27.92M |
| October 16, 2024 | 24.75M |
| October 15, 2024 | 21.94M |
| October 14, 2024 | 23.34M |
| October 11, 2024 | 22.97M |
| October 10, 2024 | 21.85M |
| October 09, 2024 | 22.61M |
| October 08, 2024 | 21.88M |
| October 07, 2024 | 22.40M |
| October 04, 2024 | 21.70M |
| October 03, 2024 | 19.61M |
| October 02, 2024 | 20.31M |
| October 01, 2024 | 21.09M |
| September 30, 2024 | 23.11M |
| September 27, 2024 | 20.44M |
| September 26, 2024 | 19.12M |
| September 25, 2024 | 18.42M |
| September 24, 2024 | 18.20M |
| September 23, 2024 | 18.88M |
| September 20, 2024 | 20.65M |
| September 19, 2024 | 20.57M |
| September 18, 2024 | 18.55M |
| September 17, 2024 | 18.80M |
| September 16, 2024 | 18.86M |
| September 13, 2024 | 20.05M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
3.314M
Minimum
Jun 12 2024
647.68M
Maximum
Feb 11 2021
96.41M
Average
36.96M
Median
Market Cap Benchmarks
| Emergent BioSolutions Inc | 509.33M |
| Geovax Labs Inc | 25.48M |
| Abbott Laboratories | 203.38B |
| Amicus Therapeutics Inc | 2.839B |
| United Therapeutics Corp | 16.40B |
Market Cap Related Metrics
| PS Ratio | 0.3149 |
| Price to Book Value | 0.5075 |
| Price | 0.2042 |
| Earnings Yield | -50.12K% |